FR2085641A1 - Noramidopyrine doxylamine succinate compsn - antiinflammatories analgesics and antipyretics - Google Patents

Noramidopyrine doxylamine succinate compsn - antiinflammatories analgesics and antipyretics

Info

Publication number
FR2085641A1
FR2085641A1 FR7014333A FR7014333A FR2085641A1 FR 2085641 A1 FR2085641 A1 FR 2085641A1 FR 7014333 A FR7014333 A FR 7014333A FR 7014333 A FR7014333 A FR 7014333A FR 2085641 A1 FR2085641 A1 FR 2085641A1
Authority
FR
France
Prior art keywords
noramidopyrine
antiinflammatories
antipyretics
compsn
analgesics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7014333A
Other languages
French (fr)
Other versions
FR2085641B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INVESTIGATIONS SCI PHARM
Original Assignee
INVESTIGATIONS SCI PHARM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INVESTIGATIONS SCI PHARM filed Critical INVESTIGATIONS SCI PHARM
Priority to FR7014333A priority Critical patent/FR2085641A1/en
Publication of FR2085641A1 publication Critical patent/FR2085641A1/en
Application granted granted Critical
Publication of FR2085641B1 publication Critical patent/FR2085641B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135Compounds containing heavy metals
    • A61K31/714Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compsns. contg. doxylamine succinate (I) and noramidopyrine sodium methane sulphonate (II) have increased activity compared to either ingredient alone and are free from side effects. They may be administered orally or rectally, using conventional formulations. In an example, tablets were prepd. contg. per tablet 0.0125 g. (i), 0.500 g. (II), and 0.50 g. caffeine.
FR7014333A 1970-04-20 1970-04-20 Noramidopyrine doxylamine succinate compsn - antiinflammatories analgesics and antipyretics Granted FR2085641A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7014333A FR2085641A1 (en) 1970-04-20 1970-04-20 Noramidopyrine doxylamine succinate compsn - antiinflammatories analgesics and antipyretics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7014333A FR2085641A1 (en) 1970-04-20 1970-04-20 Noramidopyrine doxylamine succinate compsn - antiinflammatories analgesics and antipyretics

Publications (2)

Publication Number Publication Date
FR2085641A1 true FR2085641A1 (en) 1971-12-31
FR2085641B1 FR2085641B1 (en) 1973-06-08

Family

ID=9054292

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7014333A Granted FR2085641A1 (en) 1970-04-20 1970-04-20 Noramidopyrine doxylamine succinate compsn - antiinflammatories analgesics and antipyretics

Country Status (1)

Country Link
FR (1) FR2085641A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2826277A1 (en) * 2000-12-20 2002-12-27 Duchesnay Inc New rapid onset formulation for treating nausea and vomiting comprises enterically coated pyridoxine HCl, doxylamine succinate and a disintegrating agent

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2826277A1 (en) * 2000-12-20 2002-12-27 Duchesnay Inc New rapid onset formulation for treating nausea and vomiting comprises enterically coated pyridoxine HCl, doxylamine succinate and a disintegrating agent
WO2003000263A1 (en) * 2000-12-20 2003-01-03 Duchesnay Inc. Rapid onset formulation
GB2383751A (en) * 2000-12-20 2003-07-09 Duchesnay Inc Rapid onset formulation
BE1014929A4 (en) * 2000-12-20 2004-06-01 Duchesnay Inc Formulation A PERIOD OF RAPID ACTION.
GB2383751B (en) * 2000-12-20 2005-02-09 Duchesnay Inc Rapid onset formulation

Also Published As

Publication number Publication date
FR2085641B1 (en) 1973-06-08

Similar Documents

Publication Publication Date Title
AU2676371A (en) Improvements in racks for storage and transfer purposes
PH10168A (en) Barbituric acid derivatives and compositions comprising them
FR2085641A1 (en) Noramidopyrine doxylamine succinate compsn - antiinflammatories analgesics and antipyretics
ZA718014B (en) Pharmaceutical formulations
IL32085A (en) P-(pyrryl-1)-phenethyl alcohols and their esters,their preparation and pharmaceutical compositions containing them
CA940452A (en) Pharmaceutical tablet
CA974882A (en) ANALGESIC COMPOSITIONS CONTAINING .alpha.-D-PROPOXYPHENE AND CHLORDIAZEPOXIDE
AU456309B2 (en) Improvements in tablets comprising pralidoxime
CA1013611A (en) Prevention of pecting related diseases in ruminants
AU439421B2 (en) Improvements in and relating to shelving
IL32037A (en) Alpha-substituted-2aminomethyl benzyl alcohols,their preparation and pharmaceutical compositions containing them
CA836534A (en) Anthelmintic compositions and feedstuffs and their use for combatting parasitic helminths in animals
CA852187A (en) Compositions for treating coccidiosis in poultry containing 5-methyl-3-sulfanilamidoisoxazole and 2,4-diamino-5-(3,4-di-methoxybenzyl)-pyrimidine
IL34509A (en) Bicyclo(2.2.2.)octanemethyl carbonates of 17beta-hydroxy-3-oxo-androstanes,their preparation and pharmaceutical compositions containing them
IL36352A (en) 20-imino-14 alpha,17 alpha-ethylidenedioxy-19-nor pregnatetraene derivatives,their preparation and pharmaceutical compositions containing them
CA858578A (en) Dithiosemicarbazones having coccidiostatic activity
AU1324770A (en) Improvements in smoking arrangements
AU456813B2 (en) 1, 3 dihydro-5 aryl-1, 4 benzodiazepin-2 ones
CA849879A (en) Stack chair
AU462830B2 (en) Substituted imidzoles, their preparations and pharmaceutical use
AU452217B2 (en) Improvements in or relating to furniture
AU451450B2 (en) Improvements in soled lubricants
CA859611A (en) Furniture units
IL31090A0 (en) Pharmaceutical compositions of 4-phenyl-bicyclo(2.2.2)-octane,and oct-2-ene-1-carboxylates and methods of using same
CA834417A (en) Furniture cushions

Legal Events

Date Code Title Description
ST Notification of lapse